Sage Journals: Discover world-class research

Abstract

The etiology of multisomatoform disorder (MSD) is largely unknown, but an influence of genetic factors is likely. Since pain is a major component of MSD and dopamine as well as serotonin are involved in pain pathways, genes of the dopaminergic and serotonergic system are promising candidate genes and we assumed that polymorphisms could be associated with MSD. One hundred forty-nine patients with MSD and 149 age- and gender-matched healthy controls participated in this study. DNA from all participants was genotyped for 22 single nucleotide polymorphisms (SNPs) within genes of the dopaminergic and serotonergic system by polymerase chain reaction, a restriction enzyme analysis, and pyrosequencing. The distribution of SNP alleles, genotypes, and haplotypes was compared between patients and controls. Neither an allelic nor a genotypic association was found for any individual SNP, but testing for a haplotypic association revealed that a haplotype of the serotonergic genes HT_1B and HT_1D indicated a lower risk. However, this statistically insignificant protective effect became highly significant on the background of two DAT1 haplotypes. Interestingly, if these two DAT1 haplotypes are analyzed without considering the serotonergic genes as confounders, they are significantly associated with an enhanced risk. Taking into account observations from recent publications, this apparent contradiction might be explained with the complex interaction of the dopaminergic and serotonergic systems. To conclude, our results reveal an involvement of polymorphisms in dopaminergic and serotonergic genes in the etiology of MSD in patients of German descent, but their exact role in MSD requires further investigation.

Get full access to this article

View all access options for this article.

References

Charbit

, Akerman

, Goadsby

. 2011. Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. Pain, 152:2365-2376.

Edwards

. 2006. Genetic predictors of acute and chronic pain. Curr Rhematol Rep, 8:411-417.

Guiard

, El Mansari

, Merali

et al. 2008. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesion. Int J Neuropsychopharmacol, 11:625-639.

Jacobi

, Bernateck

, Tran

A-T

et al. 2010. Catechol-O-methyltransferase gene polymorphisms are not associated with multisomatoform disorder in a group of German multisomatoform disorder patients and healthy controls. Genet Test Mol Biomarkers, 14:293-297.

Kato

, Sullivan

, Evengard

et al. 2009. A population-based twin study of functional somatic syndromes. Psychol Med, 39:497-505.

Kroenke

. 2006. Physical symptom disorder: a simpler diagnostic category for somatization-spec- trum conditions. J Psychosom Res, 60:335-339.

Lawson

. 2008. Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatr Dis Treat, 4:1059-1071.

Nackley

, Shabalina

, Tchivileva

et al. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 314:1930-1933.

Omogui

. 2007. The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3-inflammatory profile of pain syndromes. Med Hypotheses, 69:1169-1178.

10.

Schosser

, Fuchs

, Scharl

et al. 2010. Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians. World J Biol Psychiatry, 11:417-424.

11.

Sommer

. 2006. Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep, 10:101-106.

12.

Sommer

, Häuser

, Gerhold

et al. 2008. Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain. Schmerz, 22:267-282.

13.

Treister

, Pud

, Ebstein

et al. 2009. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy human. Pain, 147:187-193.

14.

Wood

, Schweinhardt

, Jaeger

et al. 2007. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci, 25:3576-3582.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

Interaction of the Dopaminergic and Serotonergic Systems Significantly Influences the Risk for Multisomatoform Disorder: A Controlled Pilot Study

Abstract

Get full access to this article

References

Supplementary Material